Collaborative Practice Model Between Cardiologists and Clinical Pharmacists for Management of Patients With Cardiovascular Disease in an Outpatient Clinic

Annals of Pharmacotherapy

Volumn 48, Issue 3, 2014, Pages 412-419

  Ripley, Toni L ^a   Adamson, Philip B ^b   Hennebry, Thomas A ^b   Van Tuyl, Joseph S ^a   Harrison, Donald L ^a   Rathbun, R Chris ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

^b Oklahoma Heart Hospital   (United States)

Author keywords

cardiologist; cardiovascular; collaborative model; pharmacist; practice model

Indexed keywords

ADULT; AGED; CARDIOLOGIST; CARDIOLOGIST CLINICAL PHARMACIST COLLABORATION; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MIDDLE AGED; NOTE; OUTPATIENT DEPARTMENT; PHARMACIST; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; SCOPE OF PRACTICE; VERY ELDERLY;

CARDIOLOGIST; CARDIOVASCULAR; COLLABORATIVE MODEL; PHARMACIST; PRACTICE MODEL;

ACADEMIC MEDICAL CENTERS; AMBULATORY CARE FACILITIES; CARDIOVASCULAR DISEASES; COOPERATIVE BEHAVIOR; DISEASE MANAGEMENT; HUMANS; PATIENT CARE TEAM; PHARMACISTS; PHYSICIANS;

EID: 84896846975     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028013515432     Document Type: Note

References (26)

1. Go AS,Mozaffarian D,Roger VL,et al.Heart disease and stroke statistics-2013 update: a report from the American Heart Association.Circulation. 2013;127:e6-e245.
2. Foot DK,Lewis RP,Pearson TA,Beller GA.Demographics and cardiology, 1950-2050.J Am Coll Cardiol. 2000;35:1067-1081.
3. Rodgers GP,Conti JB,Feinstein JA,et al.ACC 2009 survey results and recommendations: addressing the cardiology workforce crisis: a report of the ACC Board of Trustees Workforce Task Force.J Am Coll Cardiol. 2009;54:1195-1208.
4. Heidenreich PA,Trogdon JG,Khavjou OA,et al.Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.Circulation. 2011;123:933-944.
5. Gattis WA,Hasselblad V,Whellan DJ,O'Connor CM.Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team.Arch Intern Med. 1999;159:1939-1945.
6. Wilt VM,Gums JG,Ahmed OI,Moore LM.Outcome analysis of a pharmacist-managed anticoagulation service.Pharmacotherapy. 1995;15:732-739.
7. Bond CA,Raehl CL.Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions.Pharmacotherapy. 2004;24:953-963.
8. Murray MD,Ritchey ME,Wu J,Tu W.Effect of a pharmacist on adverse drug events and medication errors in outpatients with cardiovascular disease.Arch Intern Med. 2009;169:757-763.
9. Carter BL,Rogers M,Daly J,James PA.The potency of team-based care interventions for hypertension.Arch Intern Med. 2009;169:1748-1755.
10. Murray MD,Young J,Hoke S,et al.Pharmacist intervention to improve medication adherence in heart failure: a randomized trial.Ann Intern Med. 2007;146:714-725.
11. Cording MA,Engelbrecht-Zadvorny EB,Pettit BJ,Eastham JH,Sandoval R.Development of a pharmacist-managed lipid clinic.Ann Pharmacother. 2002;36:892-904.
12. Ripley TL,Hennebry TA,Sanders TN,Harrison D,Rathbun RC.Impact of a clinical pharmacist on a cardiovascular surrogate endpoint: a pilot study.Pharm Pract. 2012;10:173-179.
13. Ford ES,Ajani UA,Croft JB,et al.Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.N Engl J Med. 2007;356:2388-2398.
14. Oklahoma Pharmacy Lawbook. http://www.ok.gov/OSBP/documents/law08.pdf. Accessed May 16, 2013.
15. Scope of contemporary pharmacy practice: roles, responsibilities, and functions of pharmacists and pharmacy technicians. a resource paper of the Council on Credentialing in Pharmacy. http://www.accp.com/docs/positions/misc/CCPwpScope_Pharmacy_Practice_2-2009.pdf. Accessed April 11, 2013.
16. Saseen JJ,Grady SE,Hansen LB,et al.Future clinical pharmacy practitioners should be board-certified specialists.Pharmacotherapy. 2006;25:1816-1825.
17. Heilmann RMF,Campbell SM,Kroner BA,et al.Evolution, current structure, and role of a primary care clinical pharmacy service in an integrated managed care organization.Ann Pharmacother. 2013;47:124-131.
18. Milfred-LaForest SK,Chow S,DiDomenico RJ,et al.Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.Pharmacotherapy. 2013;33:529-548.
19. Harris IM,Baker E,Berry TM,et al.Developing a business-practice model for pharmacy services in ambulatory settings.Pharmacotherapy. 2008;28:7e-34e.
20. Masoudi FA,Baillie CA,Wang Y,et al.The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001.Arch Intern Med. 2005;165:2069-2076.
21. Perez A,Doloresco F,Hoffman JM,et al.Economic evaluations of clinical pharmacy services: 2001-2005.Pharmacotherapy. 2008;28:285c-323c.
22. Bussey HI.Blood, sweat, and tears: wasted by Medicare's missed opportunity.Pharmacotherapy. 2004;24:1655-1658.
23. Pharmacist Services Technical Advisory Coalition. http://www.pstac.org. Accessed April 5, 2013.
24. Hume AL,Kirwin J,Bieber HL,et al.Improving care transitions: current practice and future opportunities for pharmacists.Pharmacotherapy. 2012;32:e326-e337.
25. Department of Health and Human Services. Medicare and Medicaid programs; reform of hospital and critical access hospital conditions of participation: final rule. Fed Regist. 2012;77. http://www.gpo.gov/fdsys/pkg/FR-2012-05-16/pdf/2012-11548.pdf. Accessed April 5, 2013.
26. Improving patient and health system outcomes through advanced pharmacy practice: a report to the Surgeon General 2011. http://www.usphs.gov/corpslinks/pharmacy/documents/2011AdvancedPharmacyPracticeReporttotheUSSG.pdf. Accessed April 5, 2013.